"The development of the point of care test using RECAF technology will take time given the need to perfect the technique and instrument design. There is no assurance the Company will be successful in developing this test, or that the market for this test is anywhere near the size estimated"
Look at the above disclaimer. You need a technique and an instrument, neither of which exist. A $5 test is totally unrealistic. That would not even come close to paying for the instrument, the test materials or someone to run the test. IMO, this would probably end up about the same cost as a test on a mass analyzer so why not get the more accurate test in the first place. IMO, this is a pipe dream and the disclaimer says it all.
News 
Market Data 
Discover 
